BCAL NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Southern California Bancorp Common Stock · Financial Services · Banks - Regional

Open interactive chart View report data
Latest close 21.25 USD
-0.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 11.3% above the Trend Line and sits at 89.2% of its 52-week range. The latest completed week returned -0.2%, after a 2.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.

Setup score 63 out of 100
Latest Close 21.25 USD 7 Aug 2026
1W Return -0.2% latest completed week
4W Return 2.9% short-term follow-through
12W Return 14.8% quarterly tape
Trend Breadth 73.1% 38 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.2% Latest completed week; four-week move 2.9%. Indicator stack 68/77 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 53/100 12 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.3% above the Trend Line and sits at 89.2% of its 52-week range. The latest completed week returned -0.2%, after a 2.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9212-week average 0.72

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.92Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.9% over four weeks, 14.8% over 12 weeks, and 41.2% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W-0.2%
4W2.9%
12W14.8%
26W11.5%
52W41.2%
Active trend streak8 weeks
Active weeks in one year38
Trend breadth73.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.43Latest activity-pressure read.
Pressure change12.8%Four-week change in activity pressure.
Leadership0.54Latest relative-leadership reading.
RS change129.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2026 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value83/100Relative valuation strength. Underlying universe rank 18; rank 1 is best.
Quality70/100Profitability and accounting quality. Underlying universe rank 31; rank 1 is best.
Momentum72/100Medium-term price momentum. Underlying universe rank 29; rank 1 is best.
Growth96/100Revenue and earnings growth. Underlying universe rank 5; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
11.3x
Price divided by trailing earnings.
Price / sales
2.9x
Market value relative to trailing revenue.
EV / EBITDA
7.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
79.6%
Gross profit retained from each unit of revenue.
Operating margin
36.4%
Operating profit retained from revenue.
Free-cash-flow margin
16.2%
Free cash flow generated from revenue.
Return on invested capital
10.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.7%
Latest one-year revenue growth.
EPS growth
92.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-40.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.4%
Cash dividends relative to market value.
Buyback yield
0.4%
Net share repurchases relative to market value.
Shareholder yield
1.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 12 relevant articles.

5 positive · 7 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.4%Distance below the 52-week high.
13-week volatility2.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+6.0%Week of 26 Jun.
Worst week-3.4%Week of 27 Feb.
Latest week-0.2%Week of 7 Aug.

Shape of recent returns

Strong gains1
Modest gains13
Flat weeks0
Modest losses12
Sharp losses0
Recent vol2.2%13-week weekly-return volatility.
Base vol2.8%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -1.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape63/100

Trend, activity pressure, participation, and risk combine to a 63/100 tape read.

 Indicator analysis70/100

Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 6/12.

Activity pressure 0.92; 1 reversal markers Factors79/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 36; Small Cap Core rank 33 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 12 relevant articles.

California BanCorp $BCAL Position Decreased by Arrowstreet Capital Limited Partnership Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202621.25 USD-0.2%19.09 USD16.10 USD1.430.54797.7KOn
31 Jul 202621.30 USD1.3%18.99 USD16.06 USD1.436.121.2MOn
24 Jul 202621.02 USD-1.0%18.89 USD16.02 USD1.365.641.5MOn
17 Jul 202621.23 USD2.8%18.82 USD15.98 USD1.375.171.2MOn
10 Jul 202620.66 USD-1.0%18.75 USD15.94 USD1.27-1.81762.2KOn
3 Jul 202620.86 USD0.1%18.72 USD15.90 USD1.200.91716.3KOn
26 Jun 202620.83 USD6.0%18.67 USD15.85 USD1.031.612.4MOn
19 Jun 202619.64 USD-0.2%18.61 USD15.81 USD0.68-8.421.1MOn
12 Jun 202619.67 USD2.6%18.58 USD15.77 USD0.46-5.88965.5KOff
5 Jun 202619.17 USD1.5%18.55 USD15.74 USD0.24-6.18790.0KOff
29 May 202618.89 USD-0.2%18.53 USD15.70 USD0.22-11.74537.1KOff
22 May 202618.93 USD2.3%18.51 USD15.67 USD0.17-9.17744.4KOff
15 May 202618.51 USD-3.4%18.46 USD15.64 USD0.00-10.241.0MOff
8 May 202619.16 USD2.2%18.37 USD15.60 USD-0.05-7.55843.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context